Literature DB >> 11409756

Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.

D Blum1, D Gall, L Cuvelier, S N Schiffmann.   

Abstract

3-Nitropropionic acid (3NP) is a succinate dehydrogenase inhibitor classically used to create animal models of Huntington's disease (HD). However, the effects of this neurotoxin are highly variable in the Sprague-Dawley rat strain, impeding the interest of such model in neuroprotection assays. In the present study, we found that continuous s.c. infusion of 3NP in the Lewis rat strain produces homogeneous clinical impairments as well as highly reproducible striatal lesions according to their location and size. More especially, using quantitative reconstructions, we have determined, after 5 days of treatment, that the lesion was topologically reproducible in the lateral part of the striatum in all tested rats. Thus, 3NP-treated Lewis rat provides an improved animal model for testing neuroprotective strategies in HD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409756     DOI: 10.1097/00001756-200106130-00050

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

1.  Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.

Authors:  Cristiani F Bortolatto; Cristiano R Jesse; Ethel A Wilhelm; Pietro M Chagas; Cristina W Nogueira
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors:  David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.

Authors:  Alba I Rodriguez; Alison E Willing; Samuel Saporta; Don F Cameron; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington's Disease Induced by 3-Nitropionic Acid.

Authors:  Jung-Eun Park; Soon-Tae Lee; Woo-Seok Im; Manho Kim
Journal:  J Mov Disord       Date:  2013-10-30

Review 5.  3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.

Authors:  Isaac Túnez; Inmaculada Tasset; Verónica Pérez-De La Cruz; Abel Santamaría
Journal:  Molecules       Date:  2010-02-10       Impact factor: 4.411

6.  Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain.

Authors:  Carmen Lopez-Sanchez; Virginio Garcia-Martinez; Joana Poejo; Virginio Garcia-Lopez; Jairo Salazar; Carlos Gutierrez-Merino
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.